SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0001193125-13-312572
Filing Date
2013-07-31
Accepted
2013-07-31 16:13:59
Documents
1
Group Members
DAVID J. ORFAODAVID P. FIALKOWGC ENTREPRENEURS FUND V, L.P.GENERAL CATALYST GP V, LLCGENERAL CATALYST PARTNERS V, L.P.JOEL E. CUTLER

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d576908dsc13da.htm SC 13D/A 38844
  Complete submission text file 0001193125-13-312572.txt   40610
Mailing Address c/o General Catalyst Group Management LL 20 University Road Ste 450 Cambridge MA 02138
Business Address c/o General Catalyst Group Management LL 20 University Road Ste 450 Cambridge MA 02138 617-234-7000
General Catalyst Group V LP (Filed by) CIK: 0001414929 (see all company filings)

IRS No.: 000000000
Type: SC 13D/A

Mailing Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 240 CAMBRIDGE MA 02142 617-500-2802
OvaScience, Inc. (Subject) CIK: 0001544227 (see all company filings)

IRS No.: 451472564 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-87213 | Film No.: 13999177
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences